Spaulding Rehabilitation Hospital

spauldingrehab.org

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

113

Active

34

Phase 3

1

Total enrollment

4,314

Pipeline matrix

Showing 5 of 5 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Buspirone Hydrochloride1
Buspirone placebo1
StrokeWear Motor and Behavioral Intervention1
MDMA1
Telmisartan, Metformin, Cilostazol1

Next readouts

  • 2026-06-30
  • 2026-07-31
  • 2026-12
  • 2027-12-31

Top conditions

  • Spinal Cord Injuries17
  • Stroke17
  • Chronic Pain12
  • Spinal Cord Injury7
  • Traumatic Brain Injury5
  • Fibromyalgia4
  • Cerebral Palsy4
  • Healthy4

Frequently asked questions about Spaulding Rehabilitation Hospital

How many clinical trials does Spaulding Rehabilitation Hospital have on ClinicalTrials.gov?
Spaulding Rehabilitation Hospital is listed as the lead sponsor on 113 clinical trials in ClinicalTrials.gov, 34 of which are currently active (recruiting, enrolling, or ongoing).
How many of Spaulding Rehabilitation Hospital's trials are in Phase 3?
1 of Spaulding Rehabilitation Hospital's trials are in Phase 3, spread across 5 active drug programs.
What therapeutic areas does Spaulding Rehabilitation Hospital focus on?
Spaulding Rehabilitation Hospital's most-studied conditions on ClinicalTrials.gov are Spinal Cord Injuries, Stroke, Chronic Pain, Spinal Cord Injury, Traumatic Brain Injury.
When are Spaulding Rehabilitation Hospital's next clinical trial readouts?
Spaulding Rehabilitation Hospital has 4 upcoming primary-completion readouts tracked here; the soonest is “Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors”, expected around 2026-06-30.